SEOM · Sociedad Española de Oncología Médica
Acceso Zona
de socios
Colabora con la investigación en Oncología →
SEOM · Sociedad Española de Oncología Médica
  • Conócenos
    Institucional
    • Misión, visión y valores
    • Juntas Directivas
      • 2025-2027
      • Anteriores
    • Organigrama
    • Estatutos de la Sociedad
    • Código Ético
    • Transparencia
    • SEOM sostenible
    • Presidentes SEOM
    • Asamblea General de Socios 2026
    • Fundación SEOM
    • Asociarse
    Consejo de Protectores
    Secciones
    • Bioética en Oncología
    • Cáncer Familiar y Hereditario
    • Cuidados Continuos
    • Evaluación de Resultados
    • Oncogeriatría
    • Prevención y Diagnóstico Precoz
    • Trombosis y Cáncer
    • +mir - Residentes y Adjuntos jóvenes
    Comisiones
    • Acceso
    • Asuntos Internacionales
    • Becas
    • Avales Científicos
    • Calidad
    • Grupos Cooperativos
    • Medicina de Precisión - Observatorio
    • Mujeres en Oncología
    • Recertificación
    Grupos de trabajo SEOM
    • Cáncer, Trabajo y Medioambiente
    • CICOM - Coordinadores de investigación clínica en Oncología
    • Desarrollo Precoz de Nuevas Terapias
    • Determinantes Sociales
    • Ejercicio y Cáncer
    • Humanización
    • Inteligencia Artificial
    • Medicina Privada
    • Obesidad, Metabolismo y Cáncer
    • Oncología Integrativa Basada en la Evidencia
    • Resiliencia
    • Supervivientes de cáncer
    Grupos de trabajo Multidisciplinares
    • AEEMT-SEOM
    • REDECAN-SEOM
    • SEAP-SEOM
    • SECPAL-SEOM
    • SEC-SEOM
    • SEEO-SEOM
    • SEEO-SEMO-SEOR-SEOM
    • SEFH-SEOM
    • SEGG-SEOM
    • SEHAD-SEOM
    • SEHH-SEOM
    • SEIMC-SEOM
    • SEMICYUC-SEOM
    • SEMNIM-SEOM
    • SEN-SEOM
    • SEOR-SEOM
    • SEPO-SEOM
    • SEQC-SEOM
    • SER-SEOM
  • Campus SEOM
    Congresos SEOM
    Cursos SEOM
    Jornadas SEOM
    Master SEOM
    Webinars SEOM
    Otros recursos formativos SEOM
  • Biblioteca
    Guías Clínicas
    Artículos científicos SEOM
    Informes SEOM de Evaluación de Fármacos
    Consensos Multidisciplinares
    El cáncer en cifras
    Documentos de Consentimiento Informado
    Oncoimpacto
  • Becas
    Premios y Becas SEOM
    • Convocatorias
    • Resoluciones
    • Otros Premios y Becas de interés
  • Pacientes
    5.ª Edición del Código Europeo contra el cancer (OMS)
    ¿Qué es el cáncer y cómo se desarrolla?
    Prevención del cáncer
    ¿Qué es la Medicina de Precisión?
    Información sobre tipos de cáncer
    Guía actualizada sobre los tratamientos
    Materiales dirigidos a pacientes/familiares
    Recomendaciones para pacientes con cáncer
    Consejo Genético en Cáncer
    • Unidades
    • Asesoramiento Genético Mainstream
    Oncosaludable.es
    Enlaces de interés
  • Campañas
    la M que falta
    La Silla de Enfrente
  • Prensa
    Día Mundial del Cáncer 2025
    Notas de prensa
    Revistas SEOM
    Oncopodcasts
    Videoteca SEOM
    En Oncología, cada AVANCE se escribe con Mayúsculas
    Premio Periodismo SEOM
    SEOM en los medios de comunicación
    El cáncer en cifras
    SEOM informa
    Twitter
    LinkedIn
    Instagram
Acceso Zona
de socios
SEOM, Sociedad Española de Oncología Médica · Fundación SEOM

Contacto

C/ Velázquez, 7, 3ª planta. 28001 Madrid

Horario de atención: L–J 9:00–15:00 · V 8:30–14:30

Telf: 91 577 52 81 | Fax: 91 139 35 56

seom@seom.org

SEOM

  • ¿Cómo asociarse?
  • Webmail

Legal

  • Aviso legal y condiciones de uso
  • Política de cookies
  • Política de privacidad

© 2026 SEOM · Sociedad Española de Oncología Médica. Todos los derechos reservados.·

Inicio / AstraZeneca Cancer Education and Research Scholars (ACERS) Program

AstraZeneca Cancer Education and Research Scholars (ACERS) Program

 If you're interested in this job offer, you can apply to the offer through this link.
 
Location:
Cambridge, UK
 
Salary & benefits:
Competitive
 
If you’re inspired by science and how clinical development can transform care, then this is the right program for you.
 
At AstraZeneca we are building upon our strong biologics platform to bring solutions to patients. Here, you’ll have the opportunity to make a difference in people’s lives every day. As one of the world’s premier biotechnology companies, our mission is centered on delivering life-changing products that advance world health and help fight and cure disease. As part of the selected cohort of Scholars in Oncology R&D, you’ll have an opportunity to learn from a diverse group of experts across the drug development continuum and play a pivotal role in channeling our scientific capabilities to make a positive impact on changing patients’ lives.
 
We’re constantly pushing the boundaries of science to deliver life-changing medicines to patients, with a passion for discovery and a pipeline to show for it. We’re pioneering innovative research and exploring novel pathways across key therapeutic areas including oncology, respiratory, inflammation and autoimmunity, cardiovascular and metabolic disease, and infection and vaccines. And we’re industry-leading in immunology, protein engineering and translational science. We offer a unique and strong collaborative network as part of the AstraZeneca family, as together we explore synergies between small and large molecules.
 
AstraZeneca has a dynamic environment that fosters collaboration and innovation. We attract top minds, and we nurture and build top talent.
 
Primary Responsibilities:
This is a unique opportunity to join AstraZeneca at a time of tremendous growth and acceleration in the oncology biologics portfolio. This is a fast-paced and dynamic work environment where, with increasing levels of responsibility, you will have a structured learning plan in the following domains:
  • Medical monitoring of ongoing clinical trials, the planning and conduct of clinical trials,
  • Providing long-range clinical development planning, planning and managing of clinical research projects and clinical development programs in oncology,
  • Collaborating with and providing clinical input and expertise to pre-clinical and translational sciences,
  • Learning and working with regulatory and biostatistics team
In addition, you will participate in weekly clinical and scientific meetings related to your project, participating in AstraZeneca training programs through the course of the program, and participate in internal and external AstraZeneca and scientific meetings.
 
You will serve as the lead for a longitudinal medical project. Specific duties and major responsibilities for the longitudinal medical project may include any of the following: Serve as medical monitor with primary responsibility for patient safety and conduct of assigned trials as well as overall data interpretation and safety surveillance; Establish and approve scientific methods for design and implementation of applicable clinical protocols, data collection systems, and final reports; Responsible for assisting in design of clinical development plans and overall strategy for compounds, therapeutic classes of compounds or indications in light of developments in the area of clinical and pharmaceutical oncology; Collaborate with pre-clinical and translational sciences, and senior management in assessing requirements for emerging products; Participate in the selection and management activities of CROs; Supervise project team members in planning, conducting and evaluating clinical trials; Oversee planning and management of investigator meetings, advisory boards and other scientific committees.
 
You will work in a cross functional environment with representatives from other involved line functions as well as Late-Stage Development. You will contribute to and support Department/Clinical initiatives to improve the quality and content of all clinical programs as well as the cross functional/organization processes designed to effectively deliver our R&D portfolio.
Scholars will also conduct a research project linked to their medical project and will be asked to present their data to an internal peer review group along with publishing their research in peer-reviewed publication and presenting at key scientific meetings.
 
Qualification:
You are a well-trained clinician with strong leadership skills who is driven by science and the desire to develop novel therapies for cancer patients and have the opportunity for growth and development while working in a vibrant environment and “biotech” culture. Additionally, you have a clear understanding of the drug development process (especially early phase clinical trials), protocol writing & study conduct, data review and reconciliation, the principles of translational medicine, and what it takes to lead teams successfully.
 
Essential Requirements:
Education:
  • MD or equivalent required; ideally board certified (or eligible) preferred in Oncology or Hematology/Onc.
Preferred Requirements:
  • Experience in molecular oncology and/or translational science.
  • Medical specialty and sub-specialty training and Board Certification.
  • Excellent oral and written skills, strong interpersonal and listening skills.
  • Results driven to achieve creative and sound outcomes.
  • Proven leadership skills and demonstrated ability to interact collaboratively in a cross-functional environment.
  • Ability to make sound and timely decisions; agile in learning and action oriented.
  • High level of emotional intelligence; able to deal with ambiguity.
  • Able to relate to varied level audiences across the organization; able to set priorities for team and maintain accountability; skillful in negotiating organizational boundaries and hierarchy; able to build effective teams.
Timing:
The academic program typically begins in September 2020, final timing is dependent upon nature of the medical and research project. Please note this is a two-year rotational program followed by a permanent assignment within one of the Clinical Development groups.
 
Next Steps:
To be considered for this exciting opportunity, please submit a cover letter and CV through our careers site. If you know someone who would be a great fit, please share this posting with them.
 
Closing Date:
14-Sep-2020

AstraZeneca embraces diversity and equality of opportunity. We are committed to building an inclusive and diverse team representing all backgrounds, with as wide a range of perspectives as possible, and harnessing industry-leading skills. We believe that the more inclusive we are, the better our work will be. We welcome and consider applications to join our team from all qualified candidates, regardless of their characteristics. We comply with all applicable laws and regulations on non-discrimination in employment (and recruitment), as well as work authorization and employment eligibility verification requirements.